Degree in Pharmaceutical Sciences in the University of Porto. She works in the Immuno-hemotherapy Department, IPO, Porto, Portugal and in 2003 she concluded her MSc in Oncology. From 2003 to 2005, Maria Joao worked in the group of Prof. Alberto Orfao in the CIC, University of Salamanca. After receiving the Research Proficiency in Medicine certificate in 2005 she stared doctoral training. Maria Joao developed her PhD project in IDIBAPS-Hospital Clinic, and later in Vall d’Hebron. She is researcher of the Lymphoid Neoplasms Group at the Josep Carreras Leukaemia Research Institute. She has a great deal of experience in basic and translational research and is currently a co-PI of an ongoing project of our group. She is member of the following international working groups: International Extranodal Lymphoma Study Group, International Splenic Lymphoma Study Group, EHA Lymphoma Group, and ERIC. Dr. Baptista is an active collaborator that has participated and participates in several international projects. She has completed her postdoctoral training at the National Institutes of Health in Bethesda with the group of Prof.Adrian Wiestner, where she has been developing studies to disclose the mechanism of action of Ibrutinib, a drug used to treat some lymphoid neoplasms. She is reviewer of the journals PlosOne, AIDS, Cancer Research Frontiers, European Journal of Hematology, Oncotarget and Annals of Hematology.